Ledger.Open graph →
SEC Form D · filed June 9, 2023

Adaptive Phage Therapeutics, Inc

Offering
$30.0M
Sold
$12.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
GAITHERSBURG, MD
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (22)

Carl R. Merril · Gaithersburg, MDDirectorGregory L. Merril · Gaithersburg, MDExec · Director · PromoterJesse L. Goodman · Gaithersburg, MDDirectorRaymond L. Martz · Gaithersburg, MDDirectorMartin L. Heidecker · Gaithersburg, MDDirectorJonathan L. Leff · Gaithersburg, MDDirectorJana L. Jensen · Gaithersburg, MDDirectorIan L. Hardy · Gaithersburg, MDDirectorMichael L. Orndorff · Gaithersburg, MDExecEvan L. Loh · Gaithersburg, MDDirectorSubhendu L. Basu · Gaithersburg, MDExecJonathan L. Leff · Gaithersburg, MDDirectorJana L. Jensen · Gaithersburg, MDDirectorCarl R. Merril · Gaithersburg, MDDirectorIan L. Hardy · Gaithersburg, MDDirectorMichael L. Orndorff · Gaithersburg, MDExecGregory L. Merril · Gaithersburg, MDExec · Director · PromoterJesse L. Goodman · Gaithersburg, MDDirectorRaymond L. Martz · Gaithersburg, MDDirectorMartin L. Heidecker · Gaithersburg, MDDirectorEvan L. Loh · Gaithersburg, MDDirectorSubhendu L. Basu · Gaithersburg, MDExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗